Cargando…
Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882812/ https://www.ncbi.nlm.nih.gov/pubmed/31780660 http://dx.doi.org/10.1038/s41408-019-0259-8 |
| _version_ | 1783474242992472064 |
|---|---|
| author | Wang, Jeffrey Wang, Jacqueline Lopez, Elyse Guo, Hui Zhang, Hui Liu, Yang Chen, Zhihong Huang, Shengjian Zhou, Shouhao Leeming, Angela Zhang, R. J. Jung, Dayoung Shi, Hannah Grundman, Hadley Doakes, Darian Cui, Kathleen Jiang, Changying Ahmed, Makhdum Nomie, Krystle Fang, Bingliang Wang, Michael Yao, Yixin Zhang, Liang |
| author_facet | Wang, Jeffrey Wang, Jacqueline Lopez, Elyse Guo, Hui Zhang, Hui Liu, Yang Chen, Zhihong Huang, Shengjian Zhou, Shouhao Leeming, Angela Zhang, R. J. Jung, Dayoung Shi, Hannah Grundman, Hadley Doakes, Darian Cui, Kathleen Jiang, Changying Ahmed, Makhdum Nomie, Krystle Fang, Bingliang Wang, Michael Yao, Yixin Zhang, Liang |
| author_sort | Wang, Jeffrey |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6882812 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-68828122019-12-06 Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma Wang, Jeffrey Wang, Jacqueline Lopez, Elyse Guo, Hui Zhang, Hui Liu, Yang Chen, Zhihong Huang, Shengjian Zhou, Shouhao Leeming, Angela Zhang, R. J. Jung, Dayoung Shi, Hannah Grundman, Hadley Doakes, Darian Cui, Kathleen Jiang, Changying Ahmed, Makhdum Nomie, Krystle Fang, Bingliang Wang, Michael Yao, Yixin Zhang, Liang Blood Cancer J Correspondence Nature Publishing Group UK 2019-11-28 /pmc/articles/PMC6882812/ /pubmed/31780660 http://dx.doi.org/10.1038/s41408-019-0259-8 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correspondence Wang, Jeffrey Wang, Jacqueline Lopez, Elyse Guo, Hui Zhang, Hui Liu, Yang Chen, Zhihong Huang, Shengjian Zhou, Shouhao Leeming, Angela Zhang, R. J. Jung, Dayoung Shi, Hannah Grundman, Hadley Doakes, Darian Cui, Kathleen Jiang, Changying Ahmed, Makhdum Nomie, Krystle Fang, Bingliang Wang, Michael Yao, Yixin Zhang, Liang Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma |
| title | Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma |
| title_full | Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma |
| title_fullStr | Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma |
| title_full_unstemmed | Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma |
| title_short | Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma |
| title_sort | repurposing auranofin to treat tp53-mutated or pten-deleted refractory b-cell lymphoma |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882812/ https://www.ncbi.nlm.nih.gov/pubmed/31780660 http://dx.doi.org/10.1038/s41408-019-0259-8 |
| work_keys_str_mv | AT wangjeffrey repurposingauranofintotreattp53mutatedorptendeletedrefractorybcelllymphoma AT wangjacqueline repurposingauranofintotreattp53mutatedorptendeletedrefractorybcelllymphoma AT lopezelyse repurposingauranofintotreattp53mutatedorptendeletedrefractorybcelllymphoma AT guohui repurposingauranofintotreattp53mutatedorptendeletedrefractorybcelllymphoma AT zhanghui repurposingauranofintotreattp53mutatedorptendeletedrefractorybcelllymphoma AT liuyang repurposingauranofintotreattp53mutatedorptendeletedrefractorybcelllymphoma AT chenzhihong repurposingauranofintotreattp53mutatedorptendeletedrefractorybcelllymphoma AT huangshengjian repurposingauranofintotreattp53mutatedorptendeletedrefractorybcelllymphoma AT zhoushouhao repurposingauranofintotreattp53mutatedorptendeletedrefractorybcelllymphoma AT leemingangela repurposingauranofintotreattp53mutatedorptendeletedrefractorybcelllymphoma AT zhangrj repurposingauranofintotreattp53mutatedorptendeletedrefractorybcelllymphoma AT jungdayoung repurposingauranofintotreattp53mutatedorptendeletedrefractorybcelllymphoma AT shihannah repurposingauranofintotreattp53mutatedorptendeletedrefractorybcelllymphoma AT grundmanhadley repurposingauranofintotreattp53mutatedorptendeletedrefractorybcelllymphoma AT doakesdarian repurposingauranofintotreattp53mutatedorptendeletedrefractorybcelllymphoma AT cuikathleen repurposingauranofintotreattp53mutatedorptendeletedrefractorybcelllymphoma AT jiangchangying repurposingauranofintotreattp53mutatedorptendeletedrefractorybcelllymphoma AT ahmedmakhdum repurposingauranofintotreattp53mutatedorptendeletedrefractorybcelllymphoma AT nomiekrystle repurposingauranofintotreattp53mutatedorptendeletedrefractorybcelllymphoma AT fangbingliang repurposingauranofintotreattp53mutatedorptendeletedrefractorybcelllymphoma AT wangmichael repurposingauranofintotreattp53mutatedorptendeletedrefractorybcelllymphoma AT yaoyixin repurposingauranofintotreattp53mutatedorptendeletedrefractorybcelllymphoma AT zhangliang repurposingauranofintotreattp53mutatedorptendeletedrefractorybcelllymphoma |